March 13, 2024 ( Newswire) Biotech Stock News Bites – Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, is on the NASDAQ top ten gainers list today trading at $3.1442, up $0.7842 for a gain of 33.23%. The stock’s high was $3.22.

Heron announced financial results for the three and twelve months ended December 31, 2023 and highlighted recent corporate updates.

“In the fourth quarter of 2023, Heron saw continued positive momentum and an increased sales trajectory in both our acute care and oncology care franchises, illustrating how the strategic decisions made over the past year have positioned the Company for long-term success and profitability,” said Craig Collard, Chief Executive Officer of Heron. “I am pleased to share this quarterly update and look forward to building upon what we achieved in the fourth quarter of 2023, providing substantial value and meaningful solutions in the acute care and oncology care settings.”

Business Highlights

The ZYNRELEF Vial Access Needle (“VAN”) program, to allow for the rapid preparation and administration of ZYNRELEF in the operating room, remains on track for a Prior Approval Supplement (“PAS”) submission in Q2 2024 and an anticipated launch in the second half of 2024.

The ZYNRELEF Prefilled Syringe (“PFS”), to allow for immediate use of ZYNRELEF, continues to progress with an expected submission for approval in 2026.

Gross Margin improved to 71% for the quarter, up from 58% in the same period last year.

ZYNRELEF generated record quarterly revenues of approximately $5.6 million.

The CrossLink Life Sciences, LLC partnership finalized on January 7, 2024, will ultimately provide up to 650 additional sales representatives promoting ZYNRELEF to orthopedic surgeons.

Received FDA approval of our supplemental New Drug Application (“sNDA”) for ZYNRELEF which expands the ZYNRELEF label to approximately 13 million procedures annually.

Read the company’s full news and disclaimer here:

Research more Biotech stocks with stock directory

About – Big Investing Ideas is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for sectors including mining, crypto, renewable energy, gaming, biotech, tech, sports and more. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: More disclaimer and disclosure info Learn more about publishing your news release and our other news services on the newswire and Global investors must adhere to regulations of each country. Please read privacy policy:

Follow us on Twitter @investorideas and @stocknewsbites

Follow us on Facebook

Follow us on YouTube

Sign up for free stock news alerts at


800 665 0411